RT期刊文章SR电子T1种族影响急性中风的康复干预措施(P03.150)摩根富林明神经病学神经学乔FD Lippincott Williams &威尔金斯SP P03.150 OP P03.150 VO 80是7补充A1首页莫妮卡Dhakar A1 Kumar Rajamani A1拉梅什Madhavan A1格雷戈里·诺里斯A1桑德拉Narayanan A1塞缪尔Tsappidi A1安德鲁·泽维尔A1 Seemant查图尔维迪A1 Pratik Bhattacharya年2013 UL //www.ez-admanager.com/content/80/7_Supplement/P03.150.abstract AB目的:我们的假设是,比赛会影响应对急性中风干预对于恢复和获取中风后康复。背景:种族差异存在于各个方面的流行病学和获得卫生保健。社会和种族之间的生理差异让非裔美国人(AA)处于相对劣势。设计/方法:成人缺血性中风病人接受了回顾性的图表总结血管内介入城市医疗中心。人口统计、风险因素、预处理署、基线功能状态和时间治疗是抽象的。患者接受化学干预(动脉内的tPA或静脉和动脉内的tPA);机械干预(谢谢凝块检索、半影愿望纸牌stentrieval),或多通道干预(化学和机械方法)。结果包括死亡、出血性转换,改良rankin得分(夫人)放电和放电的目的地。128名患者(35.2%白人;64.8% AA)包括在内。结果:AA有更多的高血压(87.9% vs 71.1%; p = 0.02),减少高胆固醇血症(62.7% vs 80%; p = 0.04)比白种人。 There were no differences among other risk factors. The median age and NIHSS were not significantly different. There were no statistically significant differences in the variety of chemical, mechanical or multimodal interventions offered to AA and Caucasians. Time to treatment was similar between races. In a univariate analysis, AA race predicted discharge to a subacute rehabilitation facility or nursing home (45.9% vs 25% among Caucasians; p=0.04). There were no racial differences in in-hospital death and mRS at discharge. In a multivariate regression model with backward selection, AA strongly predicted discharge to a subacute rehabilitation facility or nursing home, while Caucasians were more likely to be discharged home or to acute rehabilitation.CONCLUSIONS: Race is a strong predictor of home and rehabilitation discharge favoring Caucasians. Biological and social mechanisms underlying racial disparities in stroke care and access to interventions may also extend to stroke recovery and post-stroke rehabilitation care.Disclosure: Dr. Dhakar has nothing to disclose. Dr. Rajamani has nothing to disclose. Dr. Madhavan has received research support from Genentech. Dr. Norris has nothing to disclose. Dr. Narayanan has nothing to disclose. Dr. Tsappidi has nothing to disclose. Dr. Xavier has received personal compensation for activities with Concentric as a consultant. Dr. Chaturvedi has received personal compensation for activities with Genentech, Inc., Abbott Vascular, Boehringer Ingelheim Pharmaceuticals, Inc., and Thornhill Research. Dr. Bhattacharya has nothing to disclose.Tuesday, March 19 2013, 2:00 pm-6:30 pm